Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-02

Clinical Trial Update: Effect of Acetazolamide on Lung Water Content by Ultrasound in Lowlanders Older Than 40 Years at Altitude [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating how acetazolamide affects lung water content by ultrasound in adults over 40 at altitude.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of Zurich | Conditions: Altitude Hypoxia | Phase 4 | Status: UNKNOWN